Renata Madej-Pacholczak
Krakow Branch
Krakow, MA, Poland
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials.
Journal: Expert review of anticancer therapy
Published: May 19, 2026
Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.
Journal: The oncologist
Published: May 07, 2026
Cyclin-dependent kinase 4/6 inhibitors in granulosa cell tumors and their combination with hormonal therapy: a scoping review.
Journal: Frontiers in oncology
Published: March 31, 2026
Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.
Journal: Antibodies (Basel, Switzerland)
Published: March 26, 2026
Vascular endothelial dysfunction and echocardiographic changes in male and female patients with Fabry disease: a single-center observational study.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: December 22, 2025
Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study.
Journal: Journal of neuro-oncology
Published: December 03, 2025
Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central Europe.
Journal: The oncologist
Published: November 23, 2025
Editorial: Bispecific antibodies and their conjugates in solid tumors and hematological malignancies.
Journal: Frontiers in immunology
Published: November 23, 2025
Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 17, 2025
Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study.
Journal: Breast (Edinburgh, Scotland)
Published: October 28, 2025
Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series from CEBCC-102 study.
Journal: Breast cancer research and treatment
Published: September 09, 2025
Last Updated: 09/26/2026